1. Home
  2. KRYS vs WTM Comparison

KRYS vs WTM Comparison

Compare KRYS & WTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • WTM
  • Stock Information
  • Founded
  • KRYS 2015
  • WTM 1980
  • Country
  • KRYS United States
  • WTM Bermuda
  • Employees
  • KRYS N/A
  • WTM N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • WTM Property-Casualty Insurers
  • Sector
  • KRYS Health Care
  • WTM Finance
  • Exchange
  • KRYS Nasdaq
  • WTM Nasdaq
  • Market Cap
  • KRYS 4.3B
  • WTM 4.7B
  • IPO Year
  • KRYS 2017
  • WTM N/A
  • Fundamental
  • Price
  • KRYS $155.71
  • WTM $1,713.43
  • Analyst Decision
  • KRYS Strong Buy
  • WTM
  • Analyst Count
  • KRYS 9
  • WTM 0
  • Target Price
  • KRYS $203.22
  • WTM N/A
  • AVG Volume (30 Days)
  • KRYS 295.3K
  • WTM 29.8K
  • Earning Date
  • KRYS 11-03-2025
  • WTM 11-05-2025
  • Dividend Yield
  • KRYS N/A
  • WTM 0.06%
  • EPS Growth
  • KRYS 36.22
  • WTM N/A
  • EPS
  • KRYS 4.91
  • WTM 79.93
  • Revenue
  • KRYS $359,205,000.00
  • WTM $2,578,600,000.00
  • Revenue This Year
  • KRYS $34.33
  • WTM N/A
  • Revenue Next Year
  • KRYS $47.84
  • WTM N/A
  • P/E Ratio
  • KRYS $31.68
  • WTM $22.05
  • Revenue Growth
  • KRYS 116.08
  • WTM 12.16
  • 52 Week Low
  • KRYS $122.80
  • WTM $1,678.87
  • 52 Week High
  • KRYS $207.84
  • WTM $2,023.00
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 60.39
  • WTM 37.30
  • Support Level
  • KRYS $136.73
  • WTM $1,752.00
  • Resistance Level
  • KRYS $152.96
  • WTM $1,785.77
  • Average True Range (ATR)
  • KRYS 5.13
  • WTM 33.81
  • MACD
  • KRYS 0.11
  • WTM -10.37
  • Stochastic Oscillator
  • KRYS 97.23
  • WTM 1.54

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About WTM White Mountains Insurance Group Ltd.

White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations.

Share on Social Networks: